E P Pavlikova - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Kardiologiia|October 19, 2006

[Specific features of impairment of systolic and diastolic left ventricular functions in patients with acute myocardial infarction complicated with pulmonary edema]E P Pavlikova, I A Meraĭ, V S Moiseev

Kardiologiia|December 21, 2002

[Thrombolytic therapy of acute myocardial infarction in elderly patients. Immediate and long-term remote prognosis]E P Pavlikova, C N Tereshchenko, I P Karavaeva, et al.

Kardiologiia|March 16, 2017

[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Kardiologiia|December 23, 2015

[First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 1, 2023

[Sleep disorders and fatigue in patients with different forms of myotonic dystrophy type 1]E K Erokhina, E A Melnik, D D Lebedeva, et al.

Kardiologiia|July 29, 2020

[Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.

Kardiologiia|November 6, 2020

[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)"]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.

Kardiologiia|November 2, 2020

[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.

Kardiologiia|March 18, 2021

Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT studyV Yu Mareev, Ya A Orlova, A G Plisyk, et al.

Kardiologiia|January 13, 2023

Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19)V Yu Mareev, Yа A Orlova, A G Plisuk, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Kardiologiia|October 19, 2006

[Specific features of impairment of systolic and diastolic left ventricular functions in patients with acute myocardial infarction complicated with pulmonary edema]E P Pavlikova, I A Meraĭ, V S Moiseev

Kardiologiia|December 21, 2002

[Thrombolytic therapy of acute myocardial infarction in elderly patients. Immediate and long-term remote prognosis]E P Pavlikova, C N Tereshchenko, I P Karavaeva, et al.

Kardiologiia|March 16, 2017

[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Kardiologiia|December 23, 2015

[First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 1, 2023

[Sleep disorders and fatigue in patients with different forms of myotonic dystrophy type 1]E K Erokhina, E A Melnik, D D Lebedeva, et al.

Kardiologiia|July 29, 2020

[Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.

Kardiologiia|November 6, 2020

[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)"]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.

Kardiologiia|November 2, 2020

[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)]V Yu Mareev, Ya A Orlova, E P Pavlikova, et al.

Kardiologiia|March 18, 2021

Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT studyV Yu Mareev, Ya A Orlova, A G Plisyk, et al.

Kardiologiia|January 13, 2023

Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19)V Yu Mareev, Yа A Orlova, A G Plisuk, et al.

Pageof 2